ImmunityBio will part with 10 employees this quarter. Last fall, it cut 31 employees. The moves come as the biotech works to advance Anktiva in non-small cell lung cancer.
DelveInsight’s Advanced Cervical Cancer pipeline report depicts a robust space with 70+ active players working to develop 75+ ...
The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve overall survival in patients with advanced of metastatic non-small cell lung ...
Department of Retroperitoneal Tumor Surgery, Peking University International Hospital, Beijing, China ...
Recent advances in immunotherapy have revolutionized the treatment of breast and gynecological cancers, and current ...
The former Kate Middleton was diagnosed with cancer early in 2024, and much speculation about the state of her health has followed. Catherine, Princess of Wales, has since shared that she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback